gi dynamics inc-cdi (GIDYL:OTC US)

Executive Profile*

Background*

Mr. Robert W. Crane, Bob has been the Chief Financial Officer of GI Dynamics, Inc. since 2004 and its Company Secretary since 2007 also its Treasurer since 2012. Mr. Crane serves as the Chief Financial Officer of Microchips Inc., Seragen, Circe Biomedical, Sirtris Pharmaceuticals, GI Dynamics, Inc., I-STAT and Inkine. He serves as an Acting Chief Financial Officer of Protein Forest Inc. He served as the Chief Financial Officer of TARIS BioMedical, Inc. He served as the ... Chief Financial Officer of Predictive Biosciences Inc., until July 2008 and served as its Secretary. He served as the Chief Financial Officer of Microsulis Americas Inc. He was a Partner of Montgomery Ventures. He is a seasoned executive with strong general management and financial experience and had involvement at all levels in the starting, building, turnaround and financing of healthcare companies. Mr. Crane has been involved in nearly 20 companies in a variety of fields including diagnostics, medical devices and therapeutics including I-STAT, Seragen, InKine Pharmaceuticals, Sirtris Pharmaceuticals, Life Medical Sciences, MicroCHIPS and Predictive BioSciences. He has 20 years of extensive experience with public and private companies, corporate partnerships in the U.S. as well as Europe and Japan, fundraising both private and public, sale of companies and product lines as well as the acquisition of companies and technologies. Mr. Crane earned his MBA from Stanford and his BS in Mechanical Engineering from Massachusetts Institute of Technology.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
GIDYL:US	$0.56 USD	0.00

COMPETITOR COMPENSATION